Candel Therapeutics Inc
NASDAQ:CADL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Candel Therapeutics Inc
NASDAQ:CADL
|
US |
|
G
|
Gencor Industries Inc
AMEX:GENC
|
US |
|
I
|
Italtile Ltd
JSE:ITE
|
ZA |
|
S
|
Sekisui House Ltd
XMUN:SPH1
|
JP |
|
WillScot Holdings Corp
F:WS11
|
US |
|
S
|
Sinopharm Group Co Ltd
XMUN:X2S
|
CN |
|
C
|
Corning Inc
XMUN:GLW
|
US |
|
EDP SA
OTC:EDPFY
|
PT |
|
D
|
Dermapharm Holding SE
XHAM:DMP
|
DE |
|
Grupo Mexico SAB de CV
F:4GE
|
MX |
|
PriceSmart Inc
NASDAQ:PSMT
|
US |
|
J
|
Japan Real Estate Investment Corp
SWB:JUA
|
JP |
|
Wheaton Precious Metals Corp
TSX:WPM
|
CA |
|
K
|
Kilroy Realty Corp
F:KRC
|
US |
|
Northam Platinum Holdings Ltd
F:7JR
|
ZA |
Shareholder Yield
Current shareholder yield for CADL is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CADL Price
Candel Therapeutics Inc
| Average Annual Return | 92.22% |
| Standard Deviation of Annual Returns | 232.18% |
| Max Drawdown | -94% |
| Market Capitalization | 862.4m USD |
| Shares Outstanding | 73 270 000 |
| Percentage of Shares Shorted | 28.68% |
